DE2459373A1 - Pharmazeutische praeparate - Google Patents

Pharmazeutische praeparate

Info

Publication number
DE2459373A1
DE2459373A1 DE19742459373 DE2459373A DE2459373A1 DE 2459373 A1 DE2459373 A1 DE 2459373A1 DE 19742459373 DE19742459373 DE 19742459373 DE 2459373 A DE2459373 A DE 2459373A DE 2459373 A1 DE2459373 A1 DE 2459373A1
Authority
DE
Germany
Prior art keywords
plasma
nicotinoylglucosamine
glucosamine
nicotinoyl
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19742459373
Other languages
German (de)
English (en)
Inventor
Karl Friedrich Prof Dr Gey
Joseph Prof Dr Kiss
Hans Dr Lengsfeld
Willy Dr Schueep
Pierre-Charles Dr Wyss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2459373A1 publication Critical patent/DE2459373A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/10—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
DE19742459373 1974-01-25 1974-12-16 Pharmazeutische praeparate Pending DE2459373A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH103874 1974-01-25

Publications (1)

Publication Number Publication Date
DE2459373A1 true DE2459373A1 (de) 1975-07-31

Family

ID=4200999

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19742459373 Pending DE2459373A1 (de) 1974-01-25 1974-12-16 Pharmazeutische praeparate

Country Status (13)

Country Link
US (1) US3934009A (https=)
AU (1) AU7569174A (https=)
BE (1) BE824728A (https=)
DD (1) DD118229A5 (https=)
DE (1) DE2459373A1 (https=)
GB (1) GB1449441A (https=)
IE (1) IE40362B1 (https=)
IL (1) IL46107A (https=)
LU (1) LU71706A1 (https=)
NL (1) NL7416202A (https=)
PH (1) PH11043A (https=)
SU (1) SU568337A3 (https=)
ZA (1) ZA747446B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323561A (en) * 1977-09-06 1982-04-06 Temple University Of The Commonwealth System Of Higher Education Process of enhancing immmunogenic response in mammals by the administration of synthetic glycolipid adjuvants
IT1140962B (it) * 1980-05-20 1986-10-10 Guidotti & C Spa Labor Derivati nicotinici di glucosamina, procedimento per la preparazione e relative composizioni

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5137668B2 (https=) * 1971-09-23 1976-10-16

Also Published As

Publication number Publication date
BE824728A (fr) 1975-07-24
GB1449441A (en) 1976-09-15
IE40362B1 (en) 1979-05-09
US3934009A (en) 1976-01-20
IL46107A (en) 1977-11-30
SU568337A3 (ru) 1977-08-05
IL46107A0 (en) 1975-08-31
ZA747446B (en) 1975-12-31
IE40362L (en) 1975-07-25
PH11043A (en) 1977-10-25
DD118229A5 (https=) 1976-02-20
LU71706A1 (https=) 1976-12-31
NL7416202A (nl) 1975-07-29
AU7569174A (en) 1976-05-27

Similar Documents

Publication Publication Date Title
DE69033560T2 (de) Arzneimittel für insulinresistente diabetiker
DE69735598T2 (de) Progesterone zur behandlung oder minderung von ischemie in menopause befindlichen frauen, die östrogen bekommen
DE69125714T2 (de) Zusammensetzung für die behandlung des humanen prostata adenokarzinom
DE60020501T2 (de) Trimetazidinhaltige Matrixtablette zur verlängerten Wirkstofffreisetzung nach oraler Gabe
EP0242328A2 (de) Arzneimittel zur Behandlung von Entzündungen im Auge
DE69218557T2 (de) Stabile Zusammensetzung die ein Enalapril-Salz enthält, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3320582A1 (de) Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung
DE3115080A1 (de) Arzneimittel fuer die orale verabreichung und verfahren zu seiner herstellung
EP0224810B1 (de) Antihypertensives Kombinationspräparat
DE69131553T2 (de) Arzneimittel enthaltend Mischungen von höheren primären aliphatischen Alkoholen zur Behandlung von Hypercholesterolämie und Hyperlipoproteinämie Typ II und zur Stimulation des sexuellen Verhaltens bei Tieren und Menschen
DE2459373A1 (de) Pharmazeutische praeparate
DE3234537A1 (de) Arzneimittel zur behandlung kardiovaskulaerer erkrankungen
DE1915497C3 (de) Arzneimittel mit hypolipidaemischer und hypocholesterinaemischer Wirksamkeit
DE2161588C3 (de) Mittel zur Behandlung von Hyperlipoproteinämien
EP0206297B1 (de) 4-Amino-2-(imidazolidin-2-on-l-yl)-pyrimidin-5-carbonsäure-(N-(3-trifluormethyl-phenyl)-amide) zur antithrombotischen Prophylaxe und Behandlung sowie ihre Verwendung zur Herstellung von antithrombotisch wirksamen Arzneimitteln
DE3625459C2 (https=)
DE3718398A1 (de) Neue kombinationspraeparate mit antidepressiver wirkung
EP0005121B1 (de) Verfahren zum Stabilisieren von 4-Methyl-5-(2'-chloraethyl)-thiazol
DE2128730A1 (de) Mittel zur Kompensierung eines Dopaminmangels im Gehirn
DE2059620C3 (de) 2-(alpha-(p-Chlorphenoxy)-isobutyryl)aminoäthansulfonsäure, ihre physiologisch verträglichen Salze, Verfahren zur Herstellung dieser Verbindungen und pharmakologisch wirksame Zubereitungen derselben
DE69912383T2 (de) Arzneimittel, insbesondere zur diätetischen Verwendung, das Brenztraubensäurederivate und ein Extrakt der unreifen Pomeranze enthält
DE2708327A1 (de) Entzuendungshemmendes mittel
DE2049115C3 (de) Verwendung von Calcium-5-butylpicolinat und/oder Calcium-5-pentylpicolinat bei der Bekämpfung des Parkinsonismus mit 3-(3,4-Dihydroxyphenyl)-L-alanin (L-Dopa)
EP0013252A1 (de) Mittel zur Senkung der Herzfrequenz
DE2547572C2 (de) Dihydroxy-dithio-decahexan-Derivat sowie dieses enthaltende Arzneimittel

Legal Events

Date Code Title Description
OHJ Non-payment of the annual fee